Estimation of General Practitioner Visits, Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus and Influenza Virus, and Costs Associated With Hospitalizations, in Older Adults in France From 2010 to 2020
This study highlighted the burden of RSV disease in the adult population in France is higher than previous reported. We envisage that this model-based approach will be instrumental in evaluating the impact of RSV vaccination campaigns.
Authors
- Philippe Vanhems (ORCID: https://orcid.org/0000-0003-3188-1456)
- S. Fiévez (ORCID: https://orcid.org/0009-0009-8013-2399)
- Emilie Lambourg (ORCID: https://orcid.org/0000-0003-2712-177X)
- Vanessa Barbet (ORCID: https://orcid.org/0009-0001-2762-787X)
- Jean‐Sébastien Casalegno (ORCID: https://orcid.org/0000-0003-3271-9856)
- Caihua Liang (ORCID: https://orcid.org/0009-0004-8375-631X)
- Charles Nuttens (ORCID: https://orcid.org/0000-0001-6288-8023)
- Laurence Watier (ORCID: https://orcid.org/0000-0002-4057-1102)
- Paul Loubet (ORCID: https://orcid.org/0000-0002-1218-9432)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- E. Blanc
- Clélia Bignon-Favary
- Magali Lemaître (ORCID: https://orcid.org/0000-0001-8441-1840)
- MATHIAS VACHERET
- Hervé Liliu
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Normale Supérieure de Lyon (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Institut Pasteur (FR)
- Lyon College (US)
- Pfizer (United States) (US)
- Université de Montpellier (FR)
- Hôpital de la Croix-Rousse (FR)
- FORS – Swiss Centre of Expertise in the Social Sciences (CH)
- Hospices Civils de Lyon (FR)
- Pfizer (France) (FR)
- Centre de recherche Paul Pascal (FR)
- Institut Polytechnique de Bordeaux (FR)
- Centre International de Recherche en Infectiologie (FR)
- Pfizer (Ireland) (IE)
- Ineos (United Kingdom) (GB)
- Université de Nîmes (FR)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1093/ofid/ofaf735
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Pfizer
- GlaxoSmithKline
- Yale University
- Moderna
- Conservatoire National des Arts et Métiers